# Cystic Fibrosis - Insulin Deficiency, Early Action

> **NCT01100892** · PHASE3 · COMPLETED · sponsor: **Sydney Children's Hospitals Network** · enrollment: 100 (estimated)

## Conditions studied

- Cystic Fibrosis
- Diabetes

## Interventions

- **DRUG:** Once-daily insulin detemir

## Key facts

- **NCT ID:** NCT01100892
- **Lead sponsor:** Sydney Children's Hospitals Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2023-02
- **Final completion:** 2023-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-05-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100892, "Cystic Fibrosis - Insulin Deficiency, Early Action". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01100892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*